Is Apollo Hospitals overvalued or undervalued?

As of 5 September 2025, Apollo Hospitals' valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 71.31, an EV to EBITDA of 36.66, and a ROE of 17.61%.
In comparison to its peers, Apollo Hospitals stands out with a lower PEG ratio of 1.37, while Max Healthcare and Fortis Healthcare are deemed very expensive with PE ratios of 94.34 and 77.45, respectively. Additionally, Apollo's recent stock performance has outpaced the Sensex, with a year-to-date return of 7.00% compared to the Sensex's 3.29%, further reinforcing the attractiveness of its valuation.